Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Akkilic-Materna, M; Massone, C; Komericki, P.
Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
Acta Derm Venereol. 2011; 91(4):432-435
Doi: 10.2340/00015555-1099
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-authors Med Uni Graz
- Massone Cesare
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Basal cell carcinoma and actinic keratosis are frequent neoplasms. Topical treatments include the recently approved imiquimod cream. We describe here the case of a 68-year-old man with multiple actinic keratosis on the forehead, upper trunk and on the left cheek. In addition, an exulcerated basal cell carcinoma was observed. The patient was advised only to treat lesions on the forehead with imiquimod cream. This resulted in complete clearance of actinic keratosis within 6 weeks. At follow-up, a planned surgical excision of the basal cell carcinoma and actinic keratosis on the cheek was carried out. Histopathologically, both excision specimens no longer showed features of basal cell carcinoma or actinic keratosis, despite the fact that the imiquimod treatment was not applied to the cheek. Imiquimod cream is a topical immune response modifier, which has shown antiviral and anti-tumorous properties by inducing the production of cytokines as well as by stimulating dendritic cells and lymphocytes. Our observation supports the concept of lymphatic transport of immune cells and factors with subsequent immunological curing of tumours, not only in the treated area, but also those in the area between the imiquimod application site and the regional lymph nodes (the "lymphatic field clearance").
- Find related publications in this database (using NLM MeSH Indexing)
- Administration, Cutaneous -
- Aged -
- Aminoquinolines - administration and dosage
- Antineoplastic Agents - administration and dosage
- Biopsy -
- Carcinoma, Basal Cell - drug therapy
- Humans -
- Immunologic Factors - administration and dosage
- Keratosis, Actinic - drug therapy
- Lymphatic System - drug effects
- Male -
- Ointments -
- Skin Neoplasms - drug therapy
- Treatment Outcome -
- Find related publications in this database (Keywords)
- actinic keratoses
- basal cell carcinoma
- imiquimod
- lymphatic field clearance